Literature DB >> 14966564

Inhibition of airway remodeling in IL-5-deficient mice.

Jae Youn Cho1, Marina Miller, Kwang Je Baek, Ji Won Han, Jyothi Nayar, Sook Young Lee, Kirsti McElwain, Shauna McElwain, Stephanie Friedman, David H Broide.   

Abstract

To determine the role of IL-5 in airway remodeling, IL-5-deficient and WT mice were sensitized to OVA and challenged by repetitive administration of OVA for 3 months. IL-5-deficient mice had significantly less peribronchial fibrosis (total lung collagen content, peribronchial collagens III and V) and significantly less peribronchial smooth muscle (thickness of peribronchial smooth muscle layer, alpha-smooth muscle actin immunostaining) compared with WT mice challenged with OVA. WT mice had a significant increase in the number of peribronchial cells staining positive for major basic protein and TGF-beta. In contrast, IL-5-deficient mice had a significant reduction in the number of peribronchial cells staining positive for major basic protein, which was paralleled by a similar reduction in the number of cells staining positive for TGF-beta, suggesting that eosinophils are a significant source of TGF-beta in the remodeled airway. OVA challenge induced significantly higher levels of airway epithelial alphaVbeta6 integrin expression, as well as significantly higher levels of bioactive lung TGF-beta in WT compared with IL-5-deficient mice. Increased airway epithelial expression of alphaVbeta6 integrin may contribute to the increased activation of latent TGF-beta. These results suggest an important role for IL-5, eosinophils, alphaVbeta6, and TGF-beta in airway remodeling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966564      PMCID: PMC338264          DOI: 10.1172/JCI19133

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

Review 1.  Role of transforming growth factor beta in human disease.

Authors:  G C Blobe; W P Schiemann; H F Lodish
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

2.  Fast flowing eosinophils: signals for stopping and stepping out of blood vessels.

Authors:  David Broide
Journal:  Am J Respir Cell Mol Biol       Date:  2002-06       Impact factor: 6.914

3.  Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma.

Authors:  P S Foster; Y Ming; K I Matthei; I G Young; J Temelkovski; R K Kumar
Journal:  Lab Invest       Date:  2000-05       Impact factor: 5.662

4.  Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Authors:  M J Leckie; A ten Brinke; J Khan; Z Diamant; B J O'Connor; C M Walls; A K Mathur; H C Cowley; K F Chung; R Djukanovic; T T Hansel; S T Holgate; P J Sterk; P J Barnes
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

5.  The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin.

Authors:  Simon Phipps; Sun Ying; Arun Wangoo; Yee-Ean Ong; Francesca Levi-Schaffer; A Barry Kay
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

6.  Airway smooth muscle cell proliferation is increased in asthma.

Authors:  P R Johnson; M Roth; M Tamm; M Hughes; Q Ge; G King; J K Burgess; J L Black
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

7.  Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody.

Authors:  D I Blyth; T F Wharton; M S Pedrick; T J Savage; S Sanjar
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

8.  Activation and transforming growth factor-beta production in eosinophils by hyaluronan.

Authors:  Y Ohkawara; G Tamura; T Iwasaki; A Tanaka; T Kikuchi; K Shirato
Journal:  Am J Respir Cell Mol Biol       Date:  2000-10       Impact factor: 6.914

9.  Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

Authors:  C G Lee; R J Homer; Z Zhu; S Lanone; X Wang; V Koteliansky; J M Shipley; P Gotwals; P Noble; Q Chen; R M Senior; J A Elias
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

10.  Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.

Authors:  Joerg Mattes; Ming Yang; Surendran Mahalingam; Joachim Kuehr; Dianne C Webb; Ljubov Simson; Simon P Hogan; Aulikki Koskinen; Andrew N J McKenzie; Lindsay A Dent; Marc E Rothenberg; Klaus I Matthaei; Ian G Young; Paul S Foster
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  150 in total

1.  Regulator of G-protein signaling 2 repression exacerbates airway hyper-responsiveness and remodeling in asthma.

Authors:  Haihong Jiang; Yan Xie; Peter W Abel; Dennis W Wolff; Myron L Toews; Reynold A Panettieri; Thomas B Casale; Yaping Tu
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

Review 2.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

3.  IL-13 receptor α1 differentially regulates aeroallergen-induced lung responses.

Authors:  Marc E Rothenberg; Ting Wen; Dana Shik; Eric T Cole; Melissa M Mingler; Ariel Munitz
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

4.  Adiponectin decreases pulmonary arterial remodeling in murine models of pulmonary hypertension.

Authors:  Meiqian Weng; Michael J Raher; Patricio Leyton; Terry P Combs; Philipp E Scherer; Kenneth D Bloch; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2010-11-12       Impact factor: 6.914

5.  Canonical transient receptor potential 3 channels activate NF-κB to mediate allergic airway disease via PKC-α/IκB-α and calcineurin/IκB-β pathways.

Authors:  Tengyao Song; Yun-Min Zheng; Peter A Vincent; Dongsheng Cai; Paul Rosenberg; Yong-Xiao Wang
Journal:  FASEB J       Date:  2015-09-15       Impact factor: 5.191

6.  Glycomacropeptide administration attenuates airway inflammation and remodeling associated to allergic asthma in rat.

Authors:  Nuria Renata Roldán; Mariela Jiménez; Daniel Cervantes-García; Estefanía Marín; Eva Salinas
Journal:  Inflamm Res       Date:  2016-01-11       Impact factor: 4.575

7.  Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease.

Authors:  John F Alcorn; Lisa M Rinaldi; Elizabeth F Jaffe; Mirjam van Loon; Jason H T Bates; Yvonne M W Janssen-Heininger; Charles G Irvin
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

8.  Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice.

Authors:  Nobuaki Mizutani; Takeshi Nabe; Shin Yoshino
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

Review 9.  Allergen-induced airway remodelling.

Authors:  C M Lloyd; D S Robinson
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

10.  Myosin light chain kinase is necessary for tonic airway smooth muscle contraction.

Authors:  Wen-Cheng Zhang; Ya-Jing Peng; Gen-Sheng Zhang; Wei-Qi He; Yan-Ning Qiao; Ying-Ying Dong; Yun-Qian Gao; Chen Chen; Cheng-Hai Zhang; Wen Li; Hua-Hao Shen; Wen Ning; Kristine E Kamm; James T Stull; Xiang Gao; Min-Sheng Zhu
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.